1. Alectinib induced CNS radiation necrosis in an ALK + NSCLC patient with a remote (7 years) history of brain radiation. (June 2016) Authors: Ou, Sai-Hong Ignatius; Weitz, Michael; Jalas, John R.; Kelly, Daniel F.; Wong, Vanessa; Azada, Michele C.; Quines, Oliver; Klempner, Samuel J. Journal: Lung cancer Issue: Volume 96(2016) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alectinib Induces a Durable (>15 Months) Complete Response in an ALK-Positive Non-Small Cell Lung Cancer Patient Who Progressed on Crizotinib With Diffuse Leptomeningeal Carcinomatosis. (7th January 2015) Authors: Ou, Sai-Hong Ignatius; Sommers, Karen R.; Azada, Michele C.; Garon, Edward B. Journal: Oncologist Issue: Volume 20:Number 2(2015) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alectinib Induces a Durable (>15 Months) Complete Response in an ALK‐Positive Non‐Small Cell Lung Cancer Patient Who Progressed on Crizotinib With Diffuse Leptomeningeal Carcinomatosis. (7th January 2015) Authors: Ou, Sai‐Hong Ignatius; Sommers, Karen R.; Azada, Michele C.; Garon, Edward B. Journal: Oncologist Issue: Volume 20:Number 2(2015) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression. (January 2016) Authors: Ou, Sai-Hong; Milliken, Jeffrey C.; Azada, Michele C.; Miller, Vincent A.; Ali, Siraj M.; Klempner, Samuel J. Journal: Lung cancer Issue: Volume 91(2016) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression. (January 2016) Authors: Ou, Sai-Hong; Milliken, Jeffrey C.; Azada, Michele C.; Miller, Vincent A.; Ali, Siraj M.; Klempner, Samuel J. Journal: Lung cancer Issue: Volume 91(2016) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient. Issue 2 (February 2015) Authors: Lu, Stephanie; Azada, Michele C.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient. Issue 2 (February 2015) Authors: Lu, Stephanie; Azada, Michele C.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib. Issue 2 (May 2015) Authors: Ou, Sai-Hong Ignatius; Greenbowe, Joel; Khan, Ziad U.; Azada, Michele C.; Ross, Jeffrey S.; Stevens, Phil J.; Ali, Siraj M.; Miller, Vincent A.; Gitlitz, Barbara Journal: Lung cancer Issue: Volume 88:Issue 2(2015:May) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Identification of a novel TMEM106B-ROS1 fusion variant in lung adenocarcinoma by comprehensive genomic profiling. Issue 3 (June 2015) Authors: Ou, Sai-Hong Ignatius; Chalmers, Zachary R.; Azada, Michele C.; Ross, Jeffrey S.; Stephens, Philip J.; Ali, Siraj M.; Miller, Vincent A. Journal: Lung cancer Issue: Volume 88:Issue 3(2015:Jun.) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: Implications for disease assessment and management. Issue 3 (June 2015) Authors: Ou, Sai-Hong Ignatius; Klempner, Samuel J.; Azada, Michele C.; Rausei-Mills, Veronica; Duma, Christopher Journal: Lung cancer Issue: Volume 88:Issue 3(2015:Jun.) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗